gastroenterology
Hepatology

Most people diagnosed with HCV don’t receive DAA treatment

Despite the availability of curative direct acting antiviral (DAA) therapies, most people who are newly diagnosed with hepatitis C (HCV) do not receive treatment, an Australian study has found. About a third of people who are newly diagnosed with HCV are lost to follow up or unable to access therapy because they are in prison, ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic